Zai Lab Ltd (NASDAQ:ZLAB)
| 87.84 Delayed Data As of 3:57pm ET |  -2.60 / -2.87%Today’s Change | 29.43 Today|||52-Week Range 95.52 | +111.20% Year-to-Date |
Latest ZLAB News | Press Releases
| Wall Street Breakfast: The Week Ahead Sep 20 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 90.44 |
| Today’s open | 90.28 |
| Day’s range | 87.03 - 90.28 |
| Volume | 11,572 |
| Average volume (3 months) | 383,175 |
| Market cap | $8.0B |
Data as of 3:57pm ET, 10/19/2020
Growth & Valuation
| Earnings growth (last year) | -14.94% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +9,957.04% |
| P/E ratio | NM |
| Price/Sales | 205.82 |
| Price/Book | 20.93 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRSPCRISPR Therapeutics ... | -1.92 | -1.75% |
| XLRNAcceleron Pharma Inc | -1.50 | -1.28% |
| NVAXNovavax Inc | -5.03 | -4.70% |
| NBIXNeurocrine Bioscienc... | -1.84 | -1.79% |
Data as of 5:24pm ET, 10/19/2020
Financials
| Next reporting date | December 2, 2020 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $13.0M |
| Annual profit (last year) | -$195.4M |
| Net profit margin | -1,502.28% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Shanghai, Shanghai |
Forecasts
